Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 18Brain Neoplasms 18Glioblastoma 16Glioma 15Carcinoma, Basal Cell 7Astrocytoma 5Gliosarcoma 4Skin Neoplasms 3Precancerous Conditions 3Oligodendroglioma 3Mouth Neoplasms 3Carcinoma, Squamous Cell 3Squamous Intraepithelial Lesions 2Skull Base Neoplasms 2Sarcoma 2Pituitary Neoplasms 2Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Oropharyngeal Neoplasms 1Nonmelanoma Skin Cancers 1Non-Melanoma Skin Cancer (NMSC) 1Neurofibromatosis 1 1Neurofibromatoses 1

Interventions

talimogene laherparepvec 1peginterferon alfa-2b 1nilotinib 1mirdametinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Temozolomide 1Talaporfin 1Sirolimus 1Restraint, Physical 1Ranibizumab 1Radiosurgery 1Photochemotherapy 1Neurofibromin 1 1Imatinib Mesylate 1Everolimus 1Elasticity Imaging Techniques 1Deoxycholic Acid 1Cryotherapy 1Celecoxib 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurofibroma × Aminolevulinic Acid × Clear all
NCT02728388 2025-05-08

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Medical College of Wisconsin

Phase 2 Recruiting
30 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡